Kurebayashi J, Shiba E, Toyama T, Matsumoto H, et al. A follow-up study of a randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-month depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-respons Breast Cancer 2021 Feb 27. pii: 10.1007/s12282-020-01205.
PMID: 33638810